Xu Yun-gen, Xing Ai-min, Hong Min, Sun Xiao-yu
Center of Drug Discovery, China Pharmaceutical University, Nanjing 210009, China.
Yao Xue Xue Bao. 2007 Feb;42(2):152-6.
In order to get some novel compounds with potent iNOS inhibitory activity, 12 target compounds of N-[ 4-( benzimidazole-2-thio) phenyl ] -N'-alkyl guanidine derivatives ( I1- I12 ) were synthesized from 1-benzoyl-3-[ 4-( benzimidazole-2-thio) phenyl] thioureas (4) by hydrolysis with 2. 0 mol x L(-1) sodium hydroxide solution containing tetrahydrofuran to form the corresponding N-[ 4-(benzimidazole-2-thio) phenyl] thioureas (5) which was S-ethylated with ethyl iodide, followed by amination with primary amines or secondary amines. The intermediate 4 was synthesized from 2-mercaptobenzimidazole (1) by reaction with 1-chloro-4-nitrobenzene to form 2-( 4-nitrophenylthio) benzimidazole (2) which was reduced by iron powder and hydrochloric acid, followed by reaction with benzoyl isothiocyanate. The structures of compounds I1 - I12 were confirmed by IR, MS,1H NMR and elemental analysis. The results of preliminary pharmacological test showed that the activities of three compounds (I 1, I8 and I10) were stronger than aminoguanidine, especially for compound I1.
为了获得一些具有强大诱导型一氧化氮合酶(iNOS)抑制活性的新型化合物,以1-苯甲酰基-3-[4-(苯并咪唑-2-硫基)苯基]硫脲(4)为原料,用含四氢呋喃的2.0 mol·L⁻¹氢氧化钠溶液水解,生成相应的N-[4-(苯并咪唑-2-硫基)苯基]硫脲(5),再用碘乙烷对其进行S-乙基化,然后与伯胺或仲胺进行胺化反应,合成了12种N-[4-(苯并咪唑-2-硫基)苯基]-N'-烷基胍衍生物(I1 - I12)目标化合物。中间体4由2-巯基苯并咪唑(1)与1-氯-4-硝基苯反应生成2-(4-硝基苯硫基)苯并咪唑(2),2经铁粉和盐酸还原,再与异硫氰酸苯甲酰酯反应制得。化合物I1 - I12的结构经红外光谱(IR)、质谱(MS)、¹H核磁共振谱(¹H NMR)和元素分析确证。初步药理试验结果表明,三种化合物(I1、I8和I10)的活性强于氨基胍,尤其是化合物I1。